Novo CEO pressed by Senate to cut prices of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the company would take into account new talks with insurers concerning the list costs of Wegovy and copyright if they pledge to help keep the medicines on their formularies. Do not https://daveshotchickennutrition31076.bloguetechno.com/healthcare-news-an-overview-65973659